-
Brean Murray Carret: Growth Opportunities for NetApp
Wednesday, June 27, 2012 - 8:13am | 159Read More...According to a research report published this morning, Brean Murray Carret maintains its Hold rating for NetApp Inc (NASDAQ: NTAP). Brean Murray Carret mentions in the report, “We see potential revenue catalysts although headwinds. NTAP states it captured a record number of new customers in FY12,...
-
UPDATE: Brean Murray Carret & Co. Lowers PT on Synnex to $40
Tuesday, June 26, 2012 - 12:35pm | 148Read More...Brean Murray Carret & Co. reiterates a Buy rating on Synnex (NYSE: SNX) and lowers its price target from $45 to $40. Brean Murray Carret & Co. comments, “SNX's softer‐than‐Street May revenue and EPS guidance is actually within seasonal organic revenue norms (up 5% ‐ 6%) and also suggests Q...
-
UPDATE: Brean Murray Carret Lowers Synnex Price Target due to Disappointing Retail Sales
Tuesday, June 26, 2012 - 9:13am | 158Read More...According to a research report published this morning, Brean Murray Carret reiterates a Buy rating for Synnex Corporation (NYSE: SNX) and lowers its target price from $45 to $40. Brean Murray Carret mentions in the report, “SNX suspects retail PCs were hurt this Q by macro as well as 1) drive...
-
UPDATE: Brean Murray Carret Reiterates Buy rating on Keryx Biopharmaceuticals
Friday, June 22, 2012 - 9:26am | 146Read More...In a report published earlier today, Brean Murray Carret and Co. reiterates a Buy rating on Keryx Biopharmaceuticals (NASDAQ: KERX) and a price target of $5. Brean Murray Carret and Co. comments, “At Keryx's analyst day presentation, it announced plans for two more Zerenex trials, and gave a...
-
Benzinga's Downgrade Summary for June 20, 2012
Wednesday, June 20, 2012 - 1:21pm | 686Read More...Listed below are today's Top Downgrades covered by Benzinga: Citigroup Downgrades HSN (NASDAQ: HSNI) to Neutral: Citigroup notes, "We rate HSN Neutral (2). Despite potential to accelerate buybacks and solid operating performance, we see only modest upside from current levels. …Our $42.50 target...
-
UPDATE: Brean Murray Carret Downgrades CH Energy Group to Sell on Probability of Sale to Fortis
Wednesday, June 20, 2012 - 8:00am | 94Read More...Brean Murray Carret reduces its rating on CH Energy Group (NYSE: CHG) from Hold to Sell, while keeping the price target at $65. Brean Murray Carret comments, "We are lowering our rating to Sell with a target price of $65, based on the higher probability the company is sold to Fortis, given the...
-
Three Winning Analyst Rating Trades for June 14
Thursday, June 14, 2012 - 3:47pm | 370Read More...Traders looking for equities with high-probability moves in an Up or Down direction should look no further than analyst rating changes. Stocks being reported with new ratings equivalent to "Buy" - such as upgrades to Overweight or initiations with Outperform - have a notable propensity for upward...
-
Benzinga's Initiation Summary for June 14, 2012
Thursday, June 14, 2012 - 12:21pm | 490Read More...Listed below are today's Top Initiations covered by Benzinga: Global Hunter Securities Initiates CAI International (NYSE: CAP) with Accumulate rating, $21 PT: Global Hunter Securities comments, "As one of several public container leasing companies, we believe that CAI International (CAP)...
-
UPDATE: Brean Murray Carret Initiates Coverage on Ventrus Biosciences
Thursday, June 14, 2012 - 9:54am | 174Read More...Brean Murray Carret and Co. initiates coverage of Ventrus Biosciences (NASDAQ: VTUS) at a Buy rating and a price target of $30. Brean Murray Carret and Co. comments, “We are initiating coverage of Ventrus Biosciences Inc. with a Buy rating, as we believe that VEN 309 has blockbuster potential,...
-
UPDATE: Brean Murray Carret Initiates Buy, $30 PT on Ventrus Biosciences Ahead of VEN 309 Clinical Results
Thursday, June 14, 2012 - 8:06am | 142Read More...Brean Murray Carret initiates its coverage on Ventrus Biosciences (NASDAQ: VTUS) with a Buy rating and a price target of $30. Brean Murray Carret comments, "We are initiating coverage of Ventrus Biosciences Inc. with a Buy rating, as we believe that VEN 309 has blockbuster potential, given its...
-
UPDATE: Brean Murray Carret Reiterates Buy, $16 PT on Dell; Undervalued Asset
Thursday, June 14, 2012 - 7:49am | 126Read More...Brean Murray Carret reiterates its Buy rating and $16 price target on Dell (NASDAQ: DELL) amid a softening PC environment. Brean Murray Carret notes, "We continue to view Dell as an undervalued asset (see our sum of the parts in Figures 2 & 3), while also acknowledging N‐T catalysts are tough...
-
Benzinga's Initiation Summary for May 31, 2012
Thursday, May 31, 2012 - 12:42pm | 982Read More...Listed below are today's Top Initiations at Benzinga: Global Hunter Securities Initiates Arch Coal (NYSE: ACI) at Neutral: Global Hunter Securities said, "We are initiating coverage on ACI with a Neutral rating. We project that ACI will lose money the next 3-6 quarters. Based on its average EV/...
-
Slippery May Sales for Wet Seal
Thursday, May 31, 2012 - 8:15am | 563Read More...These days, retail stores are either experiencing some of the best fiscal years in history or are operating much like they are still feeling the pangs of the recession. For a lucky few, like Rue21 (NASDAQ: RUE) and dELiA*s (NASDAQ: DLIA), sales have increased in the first quarter with hopeful...
-
Brean Murray Carret Reiterates Buy, $20 PT on Pitney Bowes on Cash Flow Confidence
Thursday, May 31, 2012 - 7:34am | 94Read More...Brean Murray Carret maintains its Buy rating and $20 price target on Pitney Bowes (NYSE: PBI). Brean Murray Carret notes, "Pitney continues feels comfortable in its ability to generate adequate cash to pay its dividend (~$300M), handle debt obligations and fund growth initiatives. PBI believes in...
-
Benzinga's Top Downgrades With Color for May 24, 2012
Thursday, May 24, 2012 - 9:44am | 363Read More...Listed below are today's Top pre-market Downgrades at Benzinga: Brean Murray Carret Downgrades NetApp (NASDAQ: NTAP) to Hold: Brean Murray Carret notes, "We're moving to Hold from Buy for now as the July Q revenue softness we spoke of in our preview is substantially greater than we'd envisioned...

